ALBIREO PHARMA INC (ALBO)
US01345P1066 - Common Stock
ChartMill assigns a Buy % Consensus number of 77% to ALBO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 42.84. This target is -2.97% below the current price.
ALBO was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ALBO.
In the previous month the buy percentage consensus was at a similar level.
ALBO was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-15 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-01-11 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-01-11 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2023-01-11 | Jefferies | Downgrade | Buy -> Hold |
| 2023-01-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-01-09 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-10-13 | HC Wainwright & Co. | Maintains | Buy |
| 2022-10-12 | Baird | Maintains | Outperform |
| 2022-09-08 | Guggenheim | Initiate | Buy |
| 2022-08-16 | Wedbush | Maintains | Outperform |
| 2022-08-16 | Baird | Maintains | Outperform |
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-17 | Baird | Maintains | Outperform |
| 2021-11-05 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-16 | Wedbush | Maintains | Outperform |
| 2021-07-21 | Wedbush | Maintains | Outperform |
| 2021-07-21 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-01 | Piper Sandler | Maintains | Overweight |